Behavioral and neurochemical effects induced by subchronic l-deprenyl administration

被引:14
作者
Molinengo, L
Ghi, P
机构
[1] Dipartimento di Anatomia, Farmacologia e Medicina Legale, Sezione di Farmacologia, Torino
关键词
deprenyl; memory retention; staircase maze; neurochemical effects;
D O I
10.1016/S0091-3057(97)00001-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Deprenyl was administered orally to rats for 15 days. In the staircase maze, a reduction of incorrect responses was observed at 0.9 mg/kg/day; higher or lower doses (3.5 or 0.35 mg/kg/day) were ineffective. In the same range of doses, the subchronic administration of(-)deprenyl did not modify the levels of norepinephrine, 5-hydroxytryptamine, 5-hydroxyindolacetic acid or the density and affinity of alpha-noradrenergic receptors in the cortex, olfactory system, hippocampus and striatum. An increase of the dopamine and a reduction of dihydroxyphenylacetic acid levels was observed only at the highest tested doses, at which no behavioral modification was observed. Only at 1.0 mg/kg/day did (-)deprenyl increase the acetylcholine (ACh) levels in the olfactory system, hippocampus and striatum. This neurochemical effect may be correlated to the behavioral effect observed in the same range of doses. We propose that this increase of ACh levels is determined by an activation of dopaminergic systems, resulting from the increase in the levels of PE caused by the inhibition of monoamine oxidase B (MAO-B) by (-)deprenyl. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 27 条
[1]   EXTRACTION OF ACETYLCHOLINE IN SMALL SAMPLES OF CEREBRAL TISSUE [J].
BEANI, L ;
BIANCHI, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1963, 15 (04) :281-&
[2]   POSSIBLE MECHANISMS OF ACTION OF (-)DEPRENYL AND OTHER MAO-B INHIBITORS IN SOME NEUROLOGIC AND PSYCHIATRIC-DISORDERS [J].
BERRY, MD ;
JUORIO, AV ;
PATERSON, IA .
PROGRESS IN NEUROBIOLOGY, 1994, 44 (02) :141-161
[3]   THE FUNCTIONAL-ROLE OF MONOAMINE OXIDASE-A AND OXIDASE-B IN THE MAMMALIAN CENTRAL-NERVOUS-SYSTEM [J].
BERRY, MD ;
JUORIO, AV ;
PATERSON, IA .
PROGRESS IN NEUROBIOLOGY, 1994, 42 (03) :375-391
[4]   IMPROVEMENT OF COGNITIVE FUNCTION BY MAO-B INHIBITOR L-DEPRENYL IN AGED RATS [J].
BRANDEIS, R ;
SAPIR, M ;
KAPON, Y ;
BORELLI, G ;
CADEL, S ;
VALSECCHI, B .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (02) :297-304
[6]   THE CONTRIBUTION OF AMPHETAMINE METABOLITES OF (-)-DEPRENYL TO ITS ANTIPARKINSONIAN PROPERTIES [J].
ELSWORTH, JD ;
SANDLER, M ;
LEES, AJ ;
WARD, C ;
STERN, GM .
JOURNAL OF NEURAL TRANSMISSION, 1982, 54 (1-2) :105-110
[7]   STRIATAL CHOLINERGIC FUNCTION REFLECTS DIFFERENCES IN D-2 DOPAMINERGIC RECEPTOR ACTIVATION [J].
FORLONI, G ;
BIDZINSKI, A ;
FUSI, R ;
LADINSKY, H ;
CONSOLO, S .
LIFE SCIENCES, 1987, 41 (14) :1717-1723
[8]   SPECIES-DIFFERENCES IN THE DEAMINATION OF DOPAMINE AND OTHER SUBSTRATES FOR MONOAMINE-OXIDASE IN BRAIN [J].
GARRICK, NA ;
MURPHY, DL .
PSYCHOPHARMACOLOGY, 1980, 72 (01) :27-33
[9]  
GELOWITZ DL, 1994, PHARM BIOCH BEHAV, V44, P41
[10]   ALPHA-ADRENOCEPTORS IN RAT-BRAIN - SODIUM CHANGES THE AFFINITY OF AGONISTS FOR PRAZOSIN SITES [J].
GLOSSMANN, H ;
HORNUNG, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 61 (04) :407-408